Sentinel node imaging in breast cancer using superficial injections: Technical details and observations

European Journal of Surgical Oncology

Volumn 35, Issue 12, 2009, Pages 1250-1256

  Somasundaram, S K ^a   Chicken, D W ^a   Waddington, W A ^b   Bomanji, J ^b   Ell, P J ^b   Keshtgar, M R S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Breast cancer; Lymphoscintigraphy; NEW START; Reporting template; Sentinel lymph node biopsy

Indexed keywords

DISULFINE BLUE; NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; HUMAN; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; GREAT BRITAIN; HUMANS; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 70449127516     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.05.006     Document Type: Article

References (23)

1. Zavagno G., De Salvo G.L., Scalco G., et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM Trial. Ann Surg 247 2 (2008) 207-213
2. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 Randomised Phase III Trial. Lancet Oncol 8 10 (2007) 881-888
3. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (2003) 546-553
4. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 9 (2006) 599-609
5. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a Randomized Controlled Trial. J Clin Oncol 23 19 (2005) 4312-4321
6. Bennett R.L., Blanks R.G., Patnick J., et al. Results from the UK NHS Breast Screening Programme 2000-05. J Med Screen 14 4 (2007) 200-204
7. MacNeill F., Mansel R., Horgan K., et al. NEW START: the United Kingdom Sentinel Lymph Biopsy Training Programme. A model of how multi-professional training can achieve competent national performance whilst maintaining patient safety. Breast Cancer Res Treat 106 (2007) S233
8. Chagpar A., Martin III R.C., Chao C., et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 139 6 (2004) 614-618
9. Goyal A., Newcombe R.G., Chhabra A., et al. Factors affecting failed localisation and false-negative rates of sentinel of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat 99 2 (2006) 203-208
10. Cody III H.S. Clinical aspects of sentinel node biopsy. Breast Cancer Res 3 2 (2001) 104-108
11. Schwartz G.F., Guiliano A.E., and Veronesi U. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J 8 3 (2002) 124-138
12. Goyal A., Newcombe R.G., Mansel R.E., et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 41 2 (2005) 238-243
13. Beenen E., and de Roy van Zuidewijn D.B. Patients blue on patent blue: an adverse reaction during four sentinel node procedures. Surg Oncol 14 4 (2005) 151-154
14. Mansouri R., Chicken D.W., and Keshtgar M.R. Allergic reactions to patent blue dye. Surg Oncol 15 1 (2006) 58
15. D'Eredita G., Giardina C., Guerrieri A.M., et al. A further validation of subareolar injection technique for breast sentinel lymph node biopsy. Ann Surg Oncol 13 5 (2006) 701-707
16. Kern K.A. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and Technetium 99m sulfur colloid. J Am Coll Surg 195 4 (2002) 467-475
17. Borgstein P.J., Meijer S., and Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 349 9066 (1997) 1668-1669
18. de Kanter A.Y., Menke-Pluijmers M.B., Henzen-Logmans S.C., et al. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement. Eur J Surg Oncol 32 5 (2006) 498-501
19. Goyal A., Douglas-Jones A.G., Newcombe R.G., et al. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 11 3 (2005) 188-194
20. Dauphine C.E., Khalkhali I., Vargas M.P., et al. Intraoperative injection of Technetium-99m sulfur colloid is effective in the detection of sentinel lymph nodes in breast cancer. Am J Surg 192 4 (2006) 423-426
21. Wang L., Yu J.M., Wang Y.S., et al. Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer. Ann Surg Oncol 14 8 (2007) 2215-2220
22. Holwitt D.M., Swatske M.E., Gillanders W.E., et al. Scientific presentation award: the combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg 196 4 (2008) 477-482
23. Britton P.D., Goud A., Godward S., et al. Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer. Eur Radiol (2008)